Clinical Values of serum CA125 and LPA determination in early diagnosis of ovarian cancer
10.3760/cma.j.issn.1008-6706.2009.11.040
- VernacularTitle:糖类抗原125、溶血磷脂酸的联合检测对早期卵巢癌诊断价值
- Author:
Zongting YAN
;
Ming HUANG
;
Maolin ZHAO
;
Aimei PANG
- Publication Type:Journal Article
- Keywords:
Ovarian Neoplasms;
Antigens
- From:
Chinese Journal of Primary Medicine and Pharmacy
2009;16(11):1993-1994
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical value of levels of CA125 and LPA as a panel for early diagnosis of ovarian cancer.Methods The levels of two tumor markers(CA125 and LPA)in serum were determined in 76 patients with ovarian cancer,35 patients with benign tumor and 29 healthy control.Results The results showed that the levels of two tumor markera in ovarian cancer patients were significantly higher than those in benign tumor patients and controls(P＜0.05).Butuo siguificant difforences was loud betwcen benigutumor patient and coatrols.Conclusion Combined detection of the two markers represent a potential biomarker for diagnosis of epithelial ovarian cancer because of its diagnostic accuracy in ovarian cancer case.
